BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Divis Laboratories Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
532488
ISIN Demat
INE361B01024
Book Value (Rs)
629.4942217
NSE Symbol
DIVISLAB
Divident Yield %
0.46
Market Cap
(Rs In Cr.)
174,543
P/E (TTM)
65.56
EPS (TTM)
100.29
Face Value
(Rs)
2
Back
Divi's Laboratories consolidated net profit rises 13.44% in the March 2026 quarter
23-May-26   Hrs IST

Net profit of Divi's Laboratories rose 13.44% to Rs 751.00 crore in the quarter ended March 2026 as against Rs 662.00 crore during the previous quarter ended March 2025. Sales rose 9.52% to Rs 2831.00 crore in the quarter ended March 2026 as against Rs 2585.00 crore during the previous quarter ended March 2025.

For the full year,net profit rose 17.21% to Rs 2568.00 crore in the year ended March 2026 as against Rs 2191.00 crore during the previous year ended March 2025. Sales rose 12.82% to Rs 10560.00 crore in the year ended March 2026 as against Rs 9360.00 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2831.002585.00 10 10560.009360.00 13
OPM %32.9934.27 -32.5931.71 -
PBDT1083.00971.00 12 3925.003318.00 18
PBT963.00864.00 11 3462.002916.00 19
NP751.00662.00 13 2568.002191.00 17

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)